Summit Securities Group’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-155
Closed -$1.84K 1160
2025
Q1
$1.84K Buy
+155
New +$1.84K ﹤0.01% 539